eli lilly oral glp-1 says its experimental pill better than Novo's Rybelsus in diabetes study Head-to-head trial shows Eli Lilly's
Description
73 (2020) S124, [37] Coskun, T., Urva, S., Roell, W
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha
If you are using a GLP-1, focus on protein, fiber, hydration, and preserving muscle
For example, a handful of cases were seen with exenatide and liraglutide, while none were reported for albiglutide or taspoglutide at the time
GLP-1 diets, restaurants, protein and fibre (KPMG)
1% reported fainting, headache, and insomnia
